Le Lézard
Classified in: Health, Business
Subject: RTG

AcelRx Pharmaceuticals added to the NASDAQ Biotechnology Index (NBI)


REDWOOD CITY, Calif., Dec. 18, 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced it has been selected for addition to the NASDAQ Biotechnology Index® (NASDAQ: NBI). AcelRx's addition to the NBI will become effective prior to market open on Monday, December 24, 2018.

The NASDAQ Biotechnology Index (NBI) contains securities of NASDAQ-listed companies that meet certain eligibility criteria, and are classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals. These requirements include minimum market capitalization, and average daily trading volume. The index is re-ranked annually and serves as the basis for the iShares NASDAQ Biotechnology Index Fund.

For more information about the NBI visit https://indexes.nasdaqomx.com/Index/Overview/NBI. 

About AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx's proprietary, non-invasive sublingual formulation technology delivers sufentanil with consistent pharmacokinetic profiles. The Company has one approved product in the U.S., DSUVIA (sufentanil sublingual tablet, 30 mcg), known as DZUVEO in Europe, indicated for the management of acute pain severe enough to require an opioid analgesic for adult patients in certified medically supervised healthcare settings, and one product candidate, Zalviso®(sufentanil sublingual tablet system, SST system, 15 mcg) being developed as an innovatively designed patient-controlled analgesia (PCA) system for reduction of moderate-to-severe acute pain in medically supervised settings. DZUVEO and Zalviso are both approved products in Europe.  For additional information about AcelRx, please visit www.acelrx.com.

AcelRx logo. (PRNewsFoto/AcelRx Pharmaceuticals, Inc.) (PRNewsfoto/AcelRx Pharmaceuticals, Inc.)

 

SOURCE AcelRx Pharmaceuticals, Inc.


These press releases may also interest you

at 04:21
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT APRIL 2024
The revenue in April for Zinzino's sales markets increased by 34 % and amounted to SEK 155.7 (116.0) million. Faun Pharma's external sales increased by 54 % and amounted to SEK 8.0 (5.2) million. Overall, the Group increased revenues by 35 % to SEK...

at 04:00
Hapag-Lloyd taps IQAX eBL to advance digital transformation of bills of lading
IQAX Ltd., an innovative developer of technology solutions for shipping and logistics based in Hong Kong, announced that Hapag-Lloyd, one of the world's largest container shipping lines, will adopt IQAX eBL to issue electronic bills of lading (eBLs)....

at 04:00
Flash News: OKX Lists ZeroLend's Token on its Spot Market
OKX, a leading crypto exchange and Web3 technology company, has issued updates for May 6, 2024. OKX Lists ZeroLend's Token on its...

at 04:00
Wynn Resorts Releases New, Updated Images of Wynn Al Marjan Island
Wynn Resorts, Limited has released new images of its latest luxury resort, Wynn Al Marjan Island, currently under construction in Ras Al Khaimah, United Arab Emirates. The development is the Company's first beachfront resort and is being built on a...

at 03:40
Steward Health Care Finalizing Financing Deal With Medical Properties Trust to Support Its Restructuring
Today, Steward Health Care ("the Company"), a national fully integrated value-based healthcare system and the largest physician-led hospital operator in the United States, announced that it has commenced an in-court restructuring process through the...

at 03:36
Liquid Wind's second eFuel facility granted environmental permit
FlagshipTWO, Sweden's second large-scale production facility of green electrofuel (eMethanol), has received the environmental permit for its planned operations in Sundsvall, Sweden. The facility is developed by Liquid Wind and is one of the largest...

More news about Business...


News published on and distributed by: